These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
701 related items for PubMed ID: 24716468
21. [New oral anticoagulants are as safe in elderly patients as conventional drugs]. Steurer J. Praxis (Bern 1994); 2014 Aug 20; 103(17):1032. PubMed ID: 25146949 [No Abstract] [Full Text] [Related]
22. [New oral anticoagulants in venous thromboembolism. General practice information on switching, monitoring, pausing]. Oberhofer E. MMW Fortschr Med; 2015 Jan 19; 157(1):24. PubMed ID: 25743289 [No Abstract] [Full Text] [Related]
23. Dabigatran, rivaroxaban and apixaban for extended venous thromboembolism treatment: network meta-analysis. Alotaibi G, Alsaleh K, Wu C, Mcmurtry MS. Int Angiol; 2014 Aug 19; 33(4):301-8. PubMed ID: 25056161 [Abstract] [Full Text] [Related]
24. Review of recently approved alternatives to anticoagulation with warfarin for emergency clinicians. Brem E, Koyfman A, Foran M. J Emerg Med; 2013 Jul 19; 45(1):143-9. PubMed ID: 23375217 [Abstract] [Full Text] [Related]
25. Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation. Lip GY, Larsen TB, Skjøth F, Rasmussen LH. J Am Coll Cardiol; 2012 Aug 21; 60(8):738-46. PubMed ID: 22575324 [Abstract] [Full Text] [Related]
26. Inhibitory effect of apixaban compared with rivaroxaban and dabigatran on thrombin generation assay. Wong PC, White A, Luettgen J. Hosp Pract (1995); 2013 Feb 21; 41(1):19-25. PubMed ID: 23466964 [Abstract] [Full Text] [Related]
27. [Laboratory diagnostic with regard to new anticoagulants - monitoring and influence on coagulation tests]. Nagler M, Wuillemin W. Ther Umsch; 2012 Nov 21; 69(11):650-6. PubMed ID: 23117668 [Abstract] [Full Text] [Related]
28. [Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors. Proposals of the Working Group on Perioperative Haemostasis (GIHP) - March 2013]. Pernod G, Albaladejo P, Godier A, Samama CM, Susen S, Gruel Y, Blais N, Fontana P, Cohen A, Llau JV, Rosencher N, Schved JF, de Maistre E, Samama MM, Mismetti P, Sié P. Ann Fr Anesth Reanim; 2013 Oct 21; 32(10):691-700. PubMed ID: 23993157 [Abstract] [Full Text] [Related]
29. Newer clinically available antithrombotics and their antidotes. Lévy S. J Interv Card Electrophysiol; 2014 Sep 21; 40(3):269-75. PubMed ID: 24934756 [Abstract] [Full Text] [Related]
30. [New oral anticoagulant agents: the quandary of anticoagulation in the elderly]. Páramo JA. Med Clin (Barc); 2013 Oct 19; 141(8):346-8. PubMed ID: 23831406 [No Abstract] [Full Text] [Related]
35. [The new Anticoagulants - Relevant Facts for the GP]. Asmis LM. Praxis (Bern 1994); 2011 Aug 10; 100(16):971-6. PubMed ID: 21833915 [Abstract] [Full Text] [Related]
36. [General characteristics of the new oral anticoagulants]. Gegu M, Chevalet P, Piloquet FX, Berrut G, De Decker L. Geriatr Psychol Neuropsychiatr Vieil; 2013 Dec 10; 11(1 Suppl):4-9. PubMed ID: 24463058 [Abstract] [Full Text] [Related]
37. Role of orally available antagonists of factor Xa in the treatment and prevention of thromboembolic disease: focus on rivaroxaban. Morell J, Sullivan B, Khalabuda M, McBride BF. J Clin Pharmacol; 2010 Sep 10; 50(9):986-1000. PubMed ID: 20124518 [Abstract] [Full Text] [Related]
39. Managing new oral anticoagulants in the intensive care unit. Gass JA, Weeks PA. Crit Care Nurs Q; 2013 Sep 10; 36(4):390-9. PubMed ID: 24002428 [Abstract] [Full Text] [Related]
40. Managing new oral anticoagulants in the perioperative and intensive care unit setting. Levy JH, Faraoni D, Spring JL, Douketis JD, Samama CM. Anesthesiology; 2013 Jun 10; 118(6):1466-74. PubMed ID: 23416382 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]